Anna Suling

Anna Suling is a Research Fellow and Head of the Clinical Studies Working Group at the University of Hamburg's Faculty of Medicine. She is affiliated with the Institute of Medical Biometry and Epidemiology within the Center for Experimental Medicine at the University Medical Center Hamburg-Eppendorf (UKE). Her expertise lies in medical biometry, clinical trial design, and epidemiological analysis. Dr. Suling leads research in cardiovascular medicine, rare diseases, and geriatric mental health, with a focus on improving clinical outcomes through evidence-based methodologies.

Key research interests include atrial fibrillation management, stroke rehabilitation, and the application of biostatistics in clinical trials. She has contributed to major studies such as the EAST-AFNET 4 trial on atrial fibrillation and the NETS trial investigating transcranial stimulation post-stroke. Her work bridges statistical rigor with clinical relevance, addressing both common and rare disease challenges.

• Educations: Dr. rer. medic (Medical Doctorate) from the University of Hamburg

Publications span interdisciplinary topics including rare disease family interventions, cardiac biomarkers, and surgical outcomes. Awards include the 2022 Biometrics Certificate from GMDS/IBS-DR, recognizing her methodological contributions. Collaborations with international consortia like EAST-AFNET highlight her role in advancing translational research.

Recent work emphasizes pragmatic trial design, such as the CARE-FAM-NET study evaluating mental health interventions for rare disease families. She also explores systemic issues like sex differences in myocardial infarction outcomes and the impact of ERAS protocols in pancreatic surgery.

• Awards: Zertifikat „Biometrie in der Medizin“ (2022)

Her advisory role in clinical studies ensures methodological excellence across diverse projects, from neurorehabilitation to genetic analyses in atrial fibrillation. Active in teaching biostatistics and mentoring early-career researchers, Dr. Suling’s work underscores the synergy between rigorous science and patient-centered care.